ENTRY       D06067                      Drug
NAME        Temozolomide (JP18/USAN/INN);
            Temodal (TN);
            Temodar (TN)
PRODUCT     TEMODAR (Merck Sharp & Dohme LLC)
  GENERIC   TEMOZOLOMIDE (Accord Healthcare)
            TEMOZOLOMIDE (Amneal Pharmaceuticals LLC)
            TEMOZOLOMIDE (Ascend Laboratories)
            TEMOZOLOMIDE (AvPAK)
            TEMOZOLOMIDE (Nivagen Pharmaceuticals)
            TEMOZOLOMIDE (Rising Pharma Holdings)
            TEMOZOLOMIDE (Rising Pharmaceuticals)
            TEMOZOLOMIDE (Sun Pharmaceutical Industries)
            TEMOZOLOMIDE (Zydus Lifesciences Limited)
            TEMOZOLOMIDE (Zydus Pharmaceuticals USA)
FORMULA     C6H6N6O2
EXACT_MASS  194.0552
MOL_WEIGHT  194.1508
CLASS       Antineoplastic
             DG01677  Alkylating agent
REMARK      Therapeutic category: 4219
            ATC code: L01AX03
            Product: D06067<JP/US>
EFFICACY    Antineoplastic, Alkylating agent
  DISEASE   Glioblastoma [DS:H00042]
            Anaplastic astrocytoma [DS:H00042]
TARGET      DNA
INTERACTION  
STR_MAP     map07040  Antineoplastics - alkylating agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01A ALKYLATING AGENTS
                L01AX Other alkylating agents
                 L01AX03 Temozolomide
                  D06067  Temozolomide (JP18/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Alkylating Agents
               Temozolomide
                D06067  Temozolomide (JP18/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               421  Alkylating agents
                4219  Others
                 D06067  Temozolomide (JP18/USAN/INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01677  Alkylating agent
               D06067  Temozolomide
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D06067
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D06067
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D06067
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D06067
DBLINKS     CAS: 85622-93-1
            PubChem: 47207725
            ChEBI: 72564
            LigandBox: D06067
            NIKKAJI: J171.234I
ATOM        14
            1   N5x N    15.4700  -20.9300
            2   N4y N    15.4700  -22.3300
            3   C8y C    16.6824  -23.0300
            4   N4y N    17.8949  -22.3300
            5   C8y C    17.8949  -20.9300
            6   N5x N    16.6824  -20.2300
            7   C8x C    19.2264  -22.7626
            8   N5x N    20.0493  -21.6300
            9   C8y C    19.2264  -20.4974
            10  O5x O    16.6824  -24.4298
            11  C1a C    14.2576  -23.0300
            12  C5a C    19.6575  -19.1706
            13  O5a O    21.0369  -18.8774
            14  N1a N    18.7311  -18.1415
BOND        15
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     1   6 2
            7     4   7 1
            8     7   8 2
            9     8   9 1
            10    5   9 2
            11    3  10 2
            12    2  11 1
            13    9  12 1
            14   12  13 2
            15   12  14 1
///
